Clinical Trial Detail

NCT ID NCT04089449
Title A Study of PRT811 in Participants With Advanced Solid Tumors, Gliomas and Myelofibrosis
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Prelude Therapeutics
Indications

malignant glioma

glioblastoma multiforme

myelofibrosis

Advanced Solid Tumor

myeloproliferative neoplasm

Therapies

PRT811

Age Groups: adult senior

No variant requirements are available.